European Review for Medical and Pharmacological Sciences - Journal - Bridge of Knowledge

Search

European Review for Medical and Pharmacological Sciences

ISSN:

1128-3602

Disciplines
(Field of Science):

  • biomedical engineering (Engineering and Technology)
  • medical biology (Medical and Health Sciences )
  • pharmacology and pharmacy (Medical and Health Sciences )
  • medical sciences (Medical and Health Sciences )
  • health sciences (Medical and Health Sciences )
  • biotechnology (Natural sciences)

Ministry points: Help

Ministry points - current year
Year Points List
Year 2024 70 Ministry scored journals list 2024
Ministry points - previous years
Year Points List
2024 70 Ministry scored journals list 2024
2023 70 Ministry Scored Journals List
2022 70 Ministry Scored Journals List 2019-2022
2021 70 Ministry Scored Journals List 2019-2022
2020 70 Ministry Scored Journals List 2019-2022
2019 70 Ministry Scored Journals List 2019-2022
2018 20 A
2017 20 A
2016 20 A
2015 15 A
2014 15 A
2013 15 A
2012 15 A
2011 15 A

Model:

Open Access

Points CiteScore:

Points CiteScore - current year
Year Points
Year 2023 5.3
Points CiteScore - previous years
Year Points
2023 5.3
2022 6.3
2021 6
2020 4.5
2019 3.5
2018 3.2
2017 3
2016 2.9
2015 2.4
2014 2
2013 1.5
2012 1.6
2011 1.6

Impact Factor:

Log in to see the Impact Factor.

Filters

total: 1

  • Category
  • Year
  • Options

clear Chosen catalog filters disabled

Catalog Journals

Year 2023
  • Microbiota-derived metabolites in colorectal cancer patients in preoperative period
    Publication
    • K. Każmierczak-Siedlecka
    • K. Skonieczna-Żydecka
    • J. Palma
    • B. K. Sobocki
    • M. Świerblewski
    • K. Siedlecka-Kroplewska
    • L. Kalinowski
    • K. Połom

    - European Review for Medical and Pharmacological Sciences - Year 2023

    Short-chain fat-ty acids (SCFAs) are microbial derived metabo-lites, which have multiple beneficial properties. The amount of SCFAs depends on several fac-tors, such as age, diet (mainly intake of dietary fiber), and overall health condition. The normal proportion between SCFAs is 3:1:1 for acetate, proprionate and butyrate, respectively. In col-orectal cancer (CRC) patients, microbiota alter-ations have been shown. Consequently,...

    Full text available to download

seen 544 times